Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non–small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study

Alexis B. Cortot, Clarisse Audigier-Valette, Olivier Molinier, Sylvestre Le Moulec, Fabrice Barlési, Gérard Zalcman, Patrick Dumont, Damien Pouessel, Claire Poulet, C. Fontaine-Delaruelle,

European Journal of Cancer · 2020 · 72 citations · 22 references

Concepts

References

22